We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Computer Program Predicts Novel Genes

By Biotechdaily staff writers
Posted on 17 Feb 2003
Researchers using a recently developed computer program that predicts novel genes have identified 1,019 previously unrecognized genes that are shared by both the mouse and human genomes. More...
Their findings were published in the February 4, 2003, issue of the Proceedings of the National Academy of Sciences.

"Whereas it might have taken 7,000 experiments to verify a thousand genes, with our method it now will take only about 1,500,” said senior author Dr. Michael R. Brent, associate professor of computer science at Washington University (St. Louis, MO, USA), who developed Twinscan, one of the programs used in the study. Twinscan predicts genes by looking at both the alignment between the two genomes and statistical patterns in the individual DNA sequences of each genome.

In the current study, the researchers employed a two-stage procedure that exploited the mouse and human genome sequences to produce a set of genes with a much higher rate of experimental verification than had been previously reported by other prediction methods. RT-PCR (reverse transcription-polymerase chain reaction) amplification and direct sequencing applied to an initial sample of mouse predictions that did not overlap previously known genes verified the regions flanking one intron in 139 predictions, with verification rates reaching 76%. The investigators verified 112 previously unknown homologs of known proteins, including two homeobox proteins relevant to developmental biology, an aquaporin, and a homolog of dystrophin. They estimated that transcription and splicing could be verified for > 1,000 gene predictions identified by this method that do not overlap known genes.

Dr. Brent said, "We now have this very sensitive and specific method for finding, predicting, and testing multi-exon genes in mammals, and we think that the method provides a very good tool for completing the catalog of multi-exon genes in humans.”



Related Links:
Washington University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.